# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-107618
Filing Date
2025-08-13
Accepted
2025-08-13 07:03:32
Documents
81
Period of Report
2025-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | spry-20250630.htm iXBRL | 10-Q | 3120443
2 | EX-10.1 | spry-ex10_1.htm | EX-10.1 | 431180
3 | EX-10.3 | spry-ex10_3.htm | EX-10.3 | 19702
4 | EX-31.1 | spry-ex31_1.htm | EX-31.1 | 16781
5 | EX-31.2 | spry-ex31_2.htm | EX-31.2 | 16755
6 | EX-32.1 | spry-ex32_1.htm | EX-32.1 | 21013
7 | GRAPHIC | img77826477_0.jpg | GRAPHIC | 484952
| Complete submission text file | 0000950170-25-107618.txt |  | 13003427

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | spry-20250630.xsd | EX-101.SCH | 1369455
84 | EXTRACTED XBRL INSTANCE DOCUMENT | spry-20250630_htm.xml | XML | 2063477

Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 251208953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)